Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074173 · ClinicalTrials.gov registry record · NA
Text My Hypertension BP Meds NOLA
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05074173 is a NA study that has completed, run by Tulane University. The registered enrollment target is 36 participants.
The verdict
NCT05074173, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The specific aims of this research study are to 1. Engage participants with poorly controlled hypertension and medication non-adherence to use simple digital approaches, specifically recurring text-messages to improve medication adherence. 2. Promote participant medication adherence and interaction with telehealth platforms with recurring text reminders on medication schedules and refills, science-based hypertension education content, and communication exchange with their health providers to improve blood pressure. 3. Evaluate the role of social support in helping participants manage their hypertension and control of Cardiovascular disease (CVD) risk factors, including daily blood pressure measurement, changes in participant quality of life, and barriers towards medication adherence, and setting goals for health behaviors.
Interventions
- BEHAVIORAL Text
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2022-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05074173
The ClinicalTrials.gov registry entry for NCT05074173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text is the first listed.
NCT05074173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05074173 about?
NCT05074173 is a clinical study titled "Text My Hypertension BP Meds NOLA". The specific aims of this research study are to 1. Engage participants with poorly controlled hypertension and medication non-adherence to use simple digital approaches, specifically recurring text-messages to improve medication adherence. 2. Promote participant medication adherence and interaction...
What is the current status of trial NCT05074173?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-10. Estimated completion is 2022-05-28.
What interventions are being tested in trial NCT05074173?
The interventions under investigation include: Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT05074173?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.